These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9490614)

  • 1. [ELISA of IgM antibodies to Thomsen-Friedenreich (TF) hapten in cancer diagnostics: comparison of data obtained with four TF-glycoconjugates].
    Smorodin EP; Jansson B; Miliukhina L; Paaski G; Bovin NV; Ovchinnikova TV; Kurtenkov O
    Bioorg Khim; 1997 Oct; 23(10):795-9. PubMed ID: 9490614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
    Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
    World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of thomsen-friedenreich-specific antibodies from human serum.
    Butschak G; Karsten U
    Tumour Biol; 2002; 23(3):113-22. PubMed ID: 12218291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection.
    Desai PR; Ujjainwala LH; Carlstedt SC; Springer GF
    J Immunol Methods; 1995 Dec; 188(2):175-85. PubMed ID: 8551046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.
    Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA
    J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
    MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
    J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
    Kodar K; Izotova J; Klaamas K; Sergeyev B; Järvekülg L; Kurtenkov O
    World J Gastroenterol; 2013 Jun; 19(23):3573-82. PubMed ID: 23801858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.
    Kurtenkov O; Izotova J; Klaamas K; Sergeyev B
    Biomed Res Int; 2014; 2014():830847. PubMed ID: 25276822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The level of IgG antibodies reactive to TF, Tn and alpha-Gal polyacrylamide-glycoconjugates in breast cancer patients: relation to survival.
    Smorodin EP; Sergeyev BL
    Exp Oncol; 2016 Jun; 38(2):117-21. PubMed ID: 27356581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates.
    Smorodin EP; Kurtenkov OA; Sergeyev BL; Pazynina GV; Bovin NV
    Glycoconj J; 2004; 20(2):83-9. PubMed ID: 15001840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of synthetic antigens with the carbohydrate structure of asialoglycophorin A for the specification of Thomsen-Friedenreich antibodies.
    Höppner W; Fischer K; Poschmann A; Paulsen H
    Vox Sang; 1985; 48(4):246-53. PubMed ID: 3984310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival.
    Kurtenkov O; Klaamas K; Mensdorff-Pouilly S; Miljukhina L; Shljapnikova L; Chuzmarov V
    Acta Oncol; 2007; 46(3):316-23. PubMed ID: 17450466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen.
    Dahlenborg K; Hultman L; Carlsson R; Jansson B
    Int J Cancer; 1997 Jan; 70(1):63-71. PubMed ID: 8985092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.
    Kurtenkov O; Klaamas K
    Dis Markers; 2015; 2015():761908. PubMed ID: 26663951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients.
    Kodar K; Kurtenkov O; Klaamas K
    Immunol Invest; 2009; 38(8):704-17. PubMed ID: 19860583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitope.
    Flechner A; Butschak G; Löffler A; Rühmann J; Nishimura SI; Dölling R; Purfürst B; Goletz S; Danielczyk A; Karsten U
    Int Immunopharmacol; 2019 Jul; 72():186-194. PubMed ID: 30999209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural IgM and IgG antibodies to Thomsen-Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors--relation to Lewis (a,b) histo-blood group phenotype.
    Kurtenkov O; Miljukhina L; Smorodin J; Klaamas K; Bovin N; Ellamaa M; Chuzmarov V
    Acta Oncol; 1999; 38(7):939-43. PubMed ID: 10606423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of the level of serum anti-TF, -Tn and -alpha-Gal IgG to survival in gastrointestinal cancer patients.
    Smorodin E; Sergeyev B; Klaamas K; Chuzmarov V; Kurtenkov O
    Int J Med Sci; 2013; 10(12):1674-82. PubMed ID: 24151439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signatures of anti-Thomsen - Friedenreich antigen antibody diversity in colon cancer patients.
    Kurtenkov O; Bubina M; Klaamas K
    Exp Oncol; 2018 Mar; 40(1):48-58. PubMed ID: 29600973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence and significance of the Thomsen-Friedenreich antigen in breast cancer. I. Serological studies.
    Newman RA; Klein PJ; Uhlenbruck G; Citoler P; Karduck D
    J Cancer Res Clin Oncol; 1979 Feb; 93(2):181-8. PubMed ID: 374421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.